| Literature DB >> 24960025 |
Maurice Theunissen1, Madelon L Peters2, Erik G W Schouten2, Audrey A A Fiddelers1, Mark G A Willemsen1, Patrícia R Pinto3, Hans-Fritz Gramke1, Marco A E Marcus4.
Abstract
OBJECTIVES: Because existing instruments for assessing surgical fear seem either too general or too limited, the Surgical Fear Questionnaire (SFQ) was developed. The aim of this study is to assess the validity and reliability of the SFQ.Entities:
Mesh:
Year: 2014 PMID: 24960025 PMCID: PMC4069058 DOI: 10.1371/journal.pone.0100225
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sociodemographic and surgery characteristics of Study 1–5.
| Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | |
| N = 1490 | N = 201 | N = 192 | N = 1275 | N = 75 | |
| Country | |||||
| NL | P | NL | NL | NL | |
| Surgery | |||||
| Mixed inpatient | Hysterectomy | Hysterectomy | Mixed | Mixed | |
| day surgery | day surgery | ||||
| Age | |||||
| 55.6±15.5 | 51.2±9.4 | 46.2±7.8 | 51.9±14.7 | 52.8±15.3 | |
| Sex | |||||
| Male | 702 | - | - | 722 | 31 |
| Female | 788 | 201 | 192 | 553 | 44 |
| Education | |||||
| Low | 392 | 188 | 33 | 396 | 20 |
| Intermediate & high | 788 | 12 | 158 | 864 | 52 |
| Missing | 310 | 1 | 1 | 15 | 3 |
| Employment | |||||
| Occupation | 484 | 99 | 129 | 688 | 34 |
| No occupation | 684 | 102 | 60 | 586 | 37 |
| Missing | 322 | 0 | 3 | 1 | 4 |
| ASA | |||||
| I/II | 1222 | 184 | 180 | 1196 | 69 |
| III/IV | 268 | 14 | 3 | 53 | 6 |
| Missing | 0 | 3 | 9 | 26 | 0 |
| Malignancy | |||||
| Yes | 239 | 0 | 0 | 107 | 7 |
| No | 1251 | 201 | 192 | 1168 | 68 |
| Preoperative pain | |||||
| 3 (0–21) | 40 (20–50) | 50 (30–60) | 20 (0–50) | 30 (0–60) | |
| Expected pain | |||||
| No/mild | 760 | 48 | 47 | 590 | 28 |
| Moderate/high | 679 | 52 | 142 | 651 | 47 |
| Missing/don't know | 51 | 101 | 3 | 34 | 0 |
N numbers baseline population; mean ± standard deviation, median (interquartile range).
Country: NL the Netherlands, P Portugal.
- Not applicable. Preoperative pain: VAS/NRS 0–100. Expected pain VAS/NRS 0–100 or Likert scale (Study 2): no/mild pain VAS/NRS <40, moderate/high pain VAS/NRS 40–100. ASA: American Society of Anesthesiologists.
SFQ scores of Study 1–5.
| Study 1 | Study 2 | Study 2 | Study 3 | Study 4 | Study 5 | |
| 10 items | 10 items | 8 items | 8 items | 8 items | 8 items | |
| SFQ | 23 (0–98) | 20 (0–82) | 13 (0–62) | 22.9 (0–77) | 22 (0–80) | 25 (0–66) |
| SFQ-s | 12 (0–40) | 9 (0–36) | 9 (0–36) | 14 (0–40) | 14 (0–40) | 14 (0–38) |
| SFQ-l | 9.5 (0–60) | 10 (0–48) | 3 (0–35) | 7 (0–38) | 8 (0–40) | 9 (0–32) |
Median (minimum-maximum).
SFQ-s: Surgical Fear Questionnaire short-time consequences (item 1–4), SFQ-l: SFQ long-term consequences (10-item version: item 5–10; 8-item version: item 5, 6, 9,10).
Exploratory factor analysis.
| Study 1 | Study 2 | ||||
| SFQ-s | SFQ-l | SFQ-s | SFQ-l | ||
| Eigenvalue | 1.211 | 4.807 | 3.588 | 1.440 | |
| 1 | Operation | 0.845 | 0.035 | 0.889 | 0.091 |
| 2 | Anaesthesia | 0.907 | −0.123 | 0.756 | 0.045 |
| 3 | Pain | 0.657 | 0.200 | 0.695 | −0.073 |
| 4 | Side effects | 0.740 | 0.054 | 0.719 | 0.034 |
| 5 | Health deterioration | 0.040 | 0.768 | 0.066 | −0.728 |
| 6 | Failed operation | 0.013 | 0.776 | −0.068 | −0.761 |
| 7 | Hospital stay | 0.256 | 0.434 | 0.393 | −0.125 |
| 8 | Family | 0.156 | 0.464 | 0.316 | −0.008 |
| 9 | Incomplete recovery | −0.114 | 0.931 | 0.094 | −0.805 |
| 10 | Long rehabilitation | −0.057 | 0.834 | −0.028 | −0.770 |
Eigenvalues and factor loadings.
Confirmatory factor analysis.
| Study 3 | Study 4 | |||
| 1 Factor | 2 Factors | 1 Factor | 2 Factors | |
| Minimum Fit Function chi square (df) | 251.9179 (20) | 88.6924 (19) | 1212.4356 (20) | 346.5056 (19) |
| RMSEA | 0.2730 | 0.1357 | 0.2495 | 0.1206 |
| Standardized RMR | 0.1010 | 0.0586 | 0.0838 | 0.0419 |
| NNFI | 0.6435 | 0.8872 | 0.7356 | 0.9236 |
| CFI | 0.7476 | 0.9235 | 0.8112 | 0.9481 |
Minimum Fit Function chi square: improvement of 2 factor model compared to 1 factor model 163.2255 (df 1), p<0.0001 (Study 3) and 865.93 (df1) p<0.0001 (Study 4). Df: degrees of freedom. RMSEA: Root Mean Square Error of Approximation, Standardized RMR: Standardized Root Mean Square Residual, NNFI: Non-Normed Fit Index, CFI: Comparative Fit Index.
Correlations of the SFQ with pain catastrophizing, expected pain, and state anxiety.
| Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | |||
| Pain Catastrophizing | / | SFQ | 0.411 | 0.442 | 0.321 | 0.451 | 0.601 |
| SFQ-s | 0.34 | 0.36 | 0.28 | 0.41 | 0.47 | ||
| SFQ-l | 0.40 | 0.41 | 0.31 | 0.42 | 0.66 | ||
| Expected Pain | / | SFQ | 0.33 | - | 0.39 | 0.48 | 0.45 |
| SFQ-s | 0.33 | - | 0.42 | 0.46 | 0.40 | ||
| SFQ-l | 0.26 | - | 0.27 | 0.42 | 0.42 | ||
| State anxiety | / | SFQ | - | 0.563 | - | - | 0.704 |
| SFQ-s | - | 0.53 | - | - | 0.62 | ||
| SFQ-l | - | 0.40 | - | - | 0.66 |
Pearson correlation, all significant at 0.01 level. - Not applicable.
SFQ: eight items; SFQ-s: Surgical Fear Questionnaire short-time consequences (item 1–4), SFQ-l: SFQ long-term consequences (item 5, 6, 9, and 10).
Catastrophizing: 1PCS: Pain Catastrophizing Scale, (Study 1, 3 and 5 13 items; Study 4 six items: I feel I can't stand it any more, I become afraid that the pain may get worse, I can't seem to keep it out of my mind, I keep thinking about how badly I want the pain to stop, there is nothing I can do to reduce the intensity of the pain, I wonder whether something serious may happen). Catastrophizing: 2CSQ-c: Coping Strategies Questionnaire-Revised, subscale pain catastrophizing.
State anxiety: 3HADS-a: Hospital Anxiety and Depression Scale, anxiety subscale.
State anxiety: 4STAI: State-Trait Anxiety Inventory, state subscale.
Sensitivity to differences in patient characteristics.
| Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | |
| Age | |||||
| <65 | 20 (9–33) | 14 (6–25)** | 22.9 (11–37) | 23 (12–37) | 25 (11–40) |
| ≥65 | 19 (8–33) | 6 (0–15) | NA | 21 (8–35) | 22 (6–35) |
| Sex | |||||
| Male | 15 (6–27)*** | NA | NA | 19 (8–31)*** | a17 (9–34) |
| Female | 24.5 (12.9–36.7) | 13 (5–24) | 22.9 (11–37) | 26 (13.3–40) | 26 (12–44) |
| Education | |||||
| Low | 22 (8.8–34.1) | a12 (4.3–23.8) | 25 (13.5–41) | b25 (11.3–39)* | 28 (6–44) |
| Intermediate & high | 19 (9–31) | 19.5 (11.8–24.5) | 21 (10–36) | 22 (11–35.7) | 25 (10.3–38.8) |
| Employment | |||||
| Occupation | a21 (10–34)** | c14 (6–28)* | 24 (11.3–36) | b22 (11–36) | 25 (10.8–38.3) |
| No occupation | 18 (8–30) | 11.5 (2.8–22) | 20 (8–38) | 23 (11–38) | 22.5 (6.5–39.3) |
| ASA | |||||
| I/II | 20 (9–33) | 14 (5–24) | 24 (11–37) | 22 (11–36) | a25 (11.3–39.8) |
| III/IV | 20.6 (9.5–33.6) | 12 (8–23) | 10 (4–NC) | 25 (12.5–36) | 9.5 (3–25) |
| Malignancy | |||||
| Yes | 20 (9–33) | NA | NA | 24.5 (13–40) | a36 (25–58)* |
| No | 20 (9–33) | 22 (11–36) | 23 (10–38) | ||
| Preoperative pain | |||||
| No/mild | 19 (8–32)*** | 14 (6.5–22) | 18.5 (7.8–32.3) | 18 (9–31)*** | 17 (6–31)** |
| Moderate/high | 26.1 (13.5–39) | 15 (5–25) | 26 (14–40) | 29 (16–42) | 35 (14–43) |
SFQ (eight items), median (interquartile range). *p<0.05, **p<0.01, ***p<0.001. NA not applicable: hysterectomy patients only, malignancy excluded; in Study 3 age ≥65 excluded. NC not calculable. ASA: American Society of Anesthesiologists.
Deviation of SFQ-short term and SFQ-long term subscale from the SFQ results is indicated as: aSFQ-s significant difference and SFQ-l non significant difference; bSFQ-s non significant difference and SFQ-l significant difference; cSFQ-s and SFQ-l non significant difference.
Preoperative pain: no/mild or VAS/NRS <40, moderate/high or VAS/NRS 40–100, Study 1: pain at time of completion questionnaire, Study 2–5: average pain last week.
Predictive validity of the SFQ, SFQ-s and SFQ-l.
| Study 1 | Study 4 | ||||
| Outcome | Predictor | OR (95 CI) | OR (95 CI) | ||
| APSP | SFQ | 2.73 | (1.59–4.69)*** | 2.35 | (1.81–3.04)*** |
| APSP | SFQ-s | 1.83 | (1.08–3.10) | 2.12 | (1.64–2.73)*** |
| APSP | SGQ-l | 3.55 | (1.99–6.32)*** | 2.62 | (2.02–3.39)*** |
| CPSP | SFQ | 1.77 | (1.25–2.51)** | 2.28 | (1.56–3.34)*** |
| CPSP | SFQ-s | 1.66 | (1.16–2.37)** | 1.66 | (1.15–2.39)** |
| CPSP | SGQ-l | 1.77 | (1.24–2.51)** | 3.05 | (2.06–4.51)*** |
| GSR | SFQ | 0.44 | (0.31–0.62)*** | 0.56 | (0.41–0.77)*** |
| GSR | SFQ-s | 0.61 | (0.43–0.87)** | 0.77 | (0.56–1.05) |
| GSR | SGQ-l | 0.44 | (0.31–0.63)*** | 0.40 | (0.29–0.55)*** |
Bivariate logistic regression with median split SFQ, SFQ short term and SFQ long term as predictor. APSP: acute postsurgical pain on day 4. CPSP: chronic postsurgical pain after 6 months in Study 1, after one year in Study 4. Pain scores were dichotomized using a cut of value of 40 for the VAS/NRS. GSR: global surgical recovery on a scale of 0–100%, values of 80–100% were considered as good recovery; long term GSR after 6 months in Study 1, after one year in Study 4.
To adjust for multiple testing a Bonferroni correction was applied: a p-value <0.017 was considered statistically significant. **p<0.01, ***p<0.001.